Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
Children's Oncology Group (COG)
Clinical Trial
Offered by: Nemours
Locations: Jacksonville, FL, Pensacola, FL
Trial Name
Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
What is the trial about?
Evaluate an investigational treatment aimed at maintaining or improving your child’s response to previous treatments.
Who can participate?
Children undergoing treatment for high risk neuroblastoma.
What is involved?
Length of study is 6 months. Tests and procedures performed include: Physical exam; Blood tests; Bone marrow tests; Various scans; Tests of kidney function; Tests of lung and heart function; Urine tests.
Contact Nemours Clinical Trials
Trial Name: Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
COG#: ANBL0032
Contact Information
(800) 354-5690
ClinicalTrials@nemours.org